HuGE Literature Finder
Records
1
-
30
| A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Frontiers in pharmacology 2023 1 13 1081952. Li Yaoting, Zeng Xuezh |
| Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma. DNA and cell biology 2023 3 42 (3): 140-150. Pan Junhai, Li Duguang, Fan Xiaoxiao, Cheng Jiaxi, Jin Shengxi, Chen Peng, Lin Hui, Li Yir |
| ADAM10 Gene Polymorphism and Its Relationship to Hepatocellular Carcinoma in Egyptian HCV Patients Receiving Direct-Acting Antiviral Therapies (DAAs). Asian Pacific journal of cancer prevention : APJCP 2023 1 24 (1): 149-155. Ghanem Samar, El Gedawy Gamalat, Yehia Sania, Bedair Hanan, Awad Samah, Abdel-Razek Wael, Elhelbawy Mostafa, El-Sabaawy Dalia, Elfert Ashraf Yous |
| An immune-related signature for optimizing prognosis prediction and treatment decision of hepatocellular carcinoma. European journal of medical research 2023 3 28 (1): 123. Yao Ninghua, Jiang Wei, Wang Yilang, Song Qianqian, Cao Xiaolei, Zheng Wenjie, Zhang J |
| Association of PNPLA3 SNP With the Development of HBV-related Hepatocellular Carcinoma. In vivo (Athens, Greece) 2023 3 37 (2): 763-770. Enomoto Hirayuki, Aizawa Nobuhiro, Ikeda Naoto, Takashima Tomoyuki, Yuri Yukihisa, Okamoto Mamiko, Yoshioka Ryota, Kawata Shoki, Yoshihara Kohei, Ota Shogo, Nakano Ryota, Shiomi Hideyuki, Nishimura Takashi, Iijima Hiro |
| Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes? Abdominal radiology (New York) 2023 3 . Liu Xiaoyang, Guo Yang, Zhao Lei, Misdraji Joseph, Kapur Tina, Abrams Thomas A, Shyn Paul |
| Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma. Vavilovskii zhurnal genetiki i selektsii 2023 3 27 (1): 72-82. Goncharova I A, Zarubin A A, Babushkina N P, Koroleva I A, Nazarenko M |
| Circulating DNA methylation profile improves the accuracy of serum biomarkers for the detection of nonmetastatic hepatocellular carcinoma. Future oncology (London, England) 2023 2 . Phan Thanh Hai, Chi Nguyen Van Thien, Thi Pham Thu Thuy, Nguyen Van-Chu, Ho Tan Dat, Quynh Pham Thi Mong, Tran Thanh-Huong, Nguyen Thanh Dat, Khang Le Nguyen Duy, Nguyen Trong-Hieu, Duong Minh-Long, Bach Hoai-Phuong Thi, Kim Van-Vu, Pham The-Anh, Nguyen Bao Toan, Vo Nguyen Thanh Nhan, Nguyen Thanh Dang, Bieu Phu Dung Thai, Huu Phan Boi Hoan, Nguyen Duy-Sinh, Truong Dinh-Kiet, Do Thanh-Thuy Thi, Giang Hoa, Nguyen Hoai-Nghia, Phan Minh-Duy, Tran Le S |
| Comprehensive investigating of mismatch repair genes (MMR) polymorphisms in participants with chronic hepatitis B virus infection. Frontiers in genetics 2023 2 14 1077297. Ma Ning, Sun Yucheng, Kong Yanan, Jin Yiyao, Yu Fengxue, Liu Lianfeng, Yang Lei, Liu Wenxuan, Gao Xia, Liu Dianwu, Zhang Xiaolin, Li |
| Diagnostic and prognostic value of STAP1 and AHNAK methylation in peripheral blood immune cells for HBV-related hepatopathy. Frontiers in immunology 2023 1 13 1091103. Sun Libo, Lu Junfeng, Li Kang, Zhang Haitao, Zhao Xiaofei, Li Guangming, Li Ni |
| Diagnostic performance of RASSF1A and CDKN2A gene methylation versus ?-fetoprotein in hepatocellular carcinoma. Clinical and experimental hepatology 2023 1 8 (3): 243-252. Nomeir Hanan, Elsheredy Heba, Nomeir Azhar, Mostafa Neveen Rashad, El-Hamshary Shaym |
| Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma. BMC cancer 2023 2 23 (1): 147. Rehman Areeba, Shabbir Maria, Badshah Yasmin, Khan Khushbukhat, Trembley Janeen H, Ashraf Naeem Mahmood, Afsar Tayyaba, Almajwal Ali, Alruwaili Nawaf W, Alshamari Ali, Alanezi Tariq Nahar, Razak Suha |
| Estrogen-related genes influence immune cell infiltration and immunotherapy response in Hepatocellular Carcinoma. Frontiers in immunology 2023 2 14 1114717. Gao Biao, Wang Yafei, Li Chonghui, Lu Shich |
| H4-methylation regulators mediated epitranscriptome patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma. Clinical epigenetics 2023 3 15 (1): 43. Yu Linyuan, Ji Tao, Liao Wei, Xu Yuyan, Fang Yinghao, Zhu Qing, Nie Jianmin, Yang Dingh |
| High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy. Journal of gastroenterology 2023 3 . Chang Xiujuan, Li Yinying, Sun Chao, Li Xiaodong, Du Wenjuan, Shang Qinghua, Song Laicheng, Long Qinghua, Li Qin, Liu Huabao, Wang Jing, Yu Zujiang, Li Jiang, Xiao Guangming, Li Li, Chen Liang, Tan Lin, Chen Yongping, Yang Yongpi |
| Hypomethylation of glycine dehydrogenase promoter in peripheral blood mononuclear cells is a new diagnostic marker of hepatitis B virus-associated hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international : HBPD INT 2023 3 . Miao Li-Li, Wang Jing-Wen, Liu Hui-Hui, Gao Shuai, Fan Yu-Chen, Wang K |
| Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment. Cancer biomarkers : section A of Disease markers 2023 3 . Yin Zi, Ma Tingting, Chen Sheng, Yu M |
| Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma. European journal of medical research 2023 1 28 (1): 46. Zhang Jianping, Gao Jie, Hu Mingchao, Xu Shiyu, Cheng Chun, Zheng Wenjie, Zhang J |
| Interactions between driver genes shape the signaling pathway landscape and direct hepatocellular carcinoma therapy. Cancer science 2023 3 . Shen Yiqing, Zheng Xiaohu, Qian Yeben, Liu Mantian, Nian Zhigang, Cui Quanwei, Zhou Yonggang, Fu Binqing, Sun Rui, Tian Zhigang, Wei Haimi |
| Long noncoding RNA polymorphisms and hepatocellular carcinoma and pancreatic cancer risk. Personalized medicine 2023 1 . Abdi Esmat, Latifi-Navid Sae |
| Molecular phenotypic linkage between N-methyladenosine methylation and tumor immune microenvironment in hepatocellular carcinoma. Journal of cancer research and clinical oncology 2023 2 . Zhang Feng, Bi Junming, Liao Jiasheng, Zhong Wenhui, Yu Min, Lu Xin, Che Jinhui, Chen Zhiyuan, Xu Haobin, Hu Shixiong, Liu Yubin, Guo Shuiji |
| Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population. Asian Pacific journal of cancer prevention : APJCP 2023 2 24 (2): 411-416. Molaei Vahid, Fattahi Mohammad Reza, Haghshenas Mohammad Reza, Hosseini Seyed Younes, Malekhosseini Seyed Ali, Sarvari Jam |
| Prediction Model with HLA-A*33:03 Reveals Number of Days to Develop Liver Cancer from Blood Test. International journal of molecular sciences 2023 3 24 (5): . Nishida Nao, Ohashi Jun, Suda Goki, Chiyoda Takehiro, Tamaki Nobuharu, Tomiyama Takahiro, Ogasawara Sachiko, Sugiyama Masaya, Kawai Yosuke, Khor Seik-Soon, Nagasaki Masao, Fujimoto Akihiro, Tsuchiura Takayo, Ishikawa Miyuki, Matsuda Koichi, Yano Hirohisa, Yoshizumi Tomoharu, Izumi Namiki, Hasegawa Kiyoshi, Sakamoto Naoya, Mizokami Masashi, Tokunaga Katsus |
| Prognosis and personalized medicine prediction by integrated whole exome and transcriptome sequencing of hepatocellular carcinoma. Frontiers in genetics 2023 2 14 1075347. Li Debao, Lei Lei, Wang Jinsong, Tang Bo, Wang Jiuling, Dong Rui, Shi Wenjiong, Liu Guo, Zhao Tingting, Wu Yuzhang, Zhang |
| Prognostic significance of the genetic variant of lymphotoxin alpha (p.Thr60Asn) in egyptian patients with advanced hepatocellular carcinoma. Molecular biology reports 2023 3 . Alhelf Maha, Shoaib Rasha M S, Elsaid Afaf, Bastawy Nermeen, Elbeltagy Nanis S, Salem Eman T, Refaat Sherif, Abuelnadar Eman |
| Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects. World journal of gastrointestinal oncology 2023 1 15 (1): 171-185. Jiang Jia-Kai, Chen Han-Shen, Tang Wei-Feng, Chen Yu, Lin Ji |
| Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib. Cancer biomarkers : section A of Disease markers 2023 3 . Lin Chih-Lang, Chien Rong-Nan, Chen Li-Wei, Chu Yu-De, Yeh Chau-Ti |
| The TM6SF2 variant as a risk factor for hepatocellular carcinoma development in chronic liver disease patients. Clinical and experimental hepatology 2023 1 8 (3): 211-218. Raia Gamal Y S, Abdelsameea Eman, Taie Dalia Hamdy Twfic, Elshaarawy Omar, Bayomy Noha Rabie, Mostafa Rasha G, Alsharnoby Aml Abd Alhamid, Diab Karema Abdelha |
| Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals. Clinical and experimental hepatology 2023 1 8 (4): 330-334. Kamal Ahmed, Mohsin Ali Kareem, Matta Cecil, Ghazy Ramy Mohamed, Elhadidi Abeer, Tahoun Mona, Rahal Amr, Domiaty Donia, Mohamed Ne |
| Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma. International journal of molecular sciences 2023 2 24 (4): . Gabbia Daniela, De Martin Sa |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: